Con: Methylprednisolone is not indicated for patients during cardiopulmonary bypass.

Journal of cardiothoracic and vascular anesthesia

Volumn 19, Issue 2, 2005, Pages 255-258

  Sulzer, Christopher F ^a   Mackensen, G Burkhard ^a   Grocott, Hilary P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENT;

CARDIOPULMONARY BYPASS; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; HUMAN; INFLAMMATION; LUNG DISEASE; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION;

ANTI-INFLAMMATORY AGENTS; CARDIOPULMONARY BYPASS; CLINICAL TRIALS; HUMANS; INFLAMMATION; LUNG DISEASES; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS; POSTOPERATIVE COMPLICATIONS;

EID: 23644460498     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2005.02.008     Document Type: Note

References (46)